Croda

Abstract The toxicological evaluation of excipients plays a crucial role in the development of SEDDS. This study examined key formulation...

Abstract Background/Objectives: Canagliflozin (CFZ) is the first sodium glucose co-transporter 2 (SGLT-2) inhibitor and is characterized by poor water solubility...

Abstract Introduction Fungal infections are common in tropical regions like India, with Candida albicans being a major causative agent. Ketoconazole, a broad-spectrum...

Abstract Surfactants such as polysorbate 20 (PS20), polysorbate 80 (PS80), and poloxamer 188 (P188) are integral to the stabilization of...

Abstract Background/Objectives: The ABCG2 transporter actively effluxes anticancer drugs, reducing their efficacy and promoting multidrug resistance (MDR). Developing oral formulations...

Abstract Lipid-based drug delivery carriers have exhibited substantial potential for promoting wound healing. Here, Phospholipon® 90H (P90H) based lipid nanoparticles...

Abstract Introduction This study explores the emulsification behavior and oral delivery performance of dry and wet inverted lipid phases (ILPdry and...

Abstract Background: Despite the growing importance of polypeptide-based drugs in clinical therapy, studies investigating the stability of their freeze-dried formulations...

Abstract Polysorbate 20 (PS20) and polysorbate 80 (PS80) are essential surfactants used to stabilize biopharmaceutical products, yet their highly heterogeneous...

PRESS RELEASE 19. November 2025 - Croda International Plc (“Croda”), a global leader in specialty ingredients, today announced a strategic...